Business Standard Gujarat Kidney ends debut session at 8% discount after listing at a premium
Gujarat Kidney and Super Speciality listed at a 5.2% premium but ended the debut session 8% below issue price amid profit-booking, even as IPO activity stayed strong in 2025
Gujarat Kidney and Super Speciality listed at a 5.2% premium but ended the debut session 8% below issue price amid profit-booking, even as IPO activity stayed strong in 2025